About Fiomi Diagnostics
Fiomi Diagnostics provides forecast technology that enables picomolar sensitivity for whole-blood In Vitro diagnostic immunoassays. The technology is based on a microstructured plastic chip which provides a flow of fluid in lateral flow assays and an fluorescence detection system providing quantitative test results.In March 2012, Fiomi Diagnostics was acquired by Trinity Biotech. The valuation of Fiomi Diagnostics was undisclosed. Other terms of the deal were not released.